Susan Kreimer

For some with lung cancer, immunotherapies are sparking long-lasting responses.

Advances in genomic technologies have made possible the development of many new, more complex tests, prompting the FDA to voice concern over health care decisions based on potentially incorrect results.

Advances in immunotherapy are showing progress in treating brain cancer, especially glioblastoma.

FDA decision changes the routine for treating cancer-related anemia.

Controversy surrounds lung cancer screening.

Patients who travel for treatment now have more places to stay.

Anyone considering traveling for cancer treatment should thoroughly research the treatment facility services, specialties and pysicians and plan ahead for a place to stay and living expenses.